is scientific director in the staff unit "International and European Affairs" of the Federal Institute for Drugs and Medical Devices (BfArM). He heads the unit "Scientific Quality in European Procedures", which is responsible for coordinating the evaluation of the content of marketing authorization dossiers. In this function he represents Germany in the Quality Working Party (QWP) of the European Medicines Agency (EMA) in Amsterdam. At the same time, he is a nominated member of the associated Core Team, in which differences in the assessment of pharmaceutical quality in central marketing authorization procedures are discussed and harmonized.
In addition to his activities in regulatory affairs, he prepares and comments on national and international guidelines and monograph drafts of the European Pharmacopoeia. Since 2020, he has been chair of the Ph.Eur. expert group 17 (multisource medicinal products); he is also a member of the PAT expert group there. He regularly participates in the Pharmaceutical Technology Committee of the German Pharmacopoeia.